Skip to main content
    N

    Nexalin Technology Inc. (NXL)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.51
    -0.05 (-3.21%)

    Market Cap: $1.93M

    Last updated: Nov 17, 2026 at 4:30 PM ET

    Nexalin Technology Inc. (NXL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Nexalin Technology (NXL) has a market cap of $1.93M and an enterprise value of $2.09M. Its share count is up 3832.21% from a year earlier. It kept -3380.59% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 8.28% above the market cap, as debt exceeds cash.

    Market Cap$1.93M
    Enterprise Value$2.09M
    Latest price (Nov 17, 2026)$1.51

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 10.31% in the quarter ended Sep 30, 2026 and grew 46.63% a year over 2 years.

    Shares Outstanding776.66K
    Shares Change (YoY)+3832.21%
    Shares Change (QoQ)+10.31%
    Share Count Growth (2Y CAGR)+46.63%

    Valuation Ratios

    Sales and book value multiples are 4.2x and 4.5x. Its year-end P/S ranged from 36.7x to 253.0x from 2022 to 2024.

    P/S Ratio4.2x
    Forward P/S10.0x
    P/B Ratio4.5x

    Valuation history and multiples

    Price Statistics

    The stock is down 95.34% over 52 weeks and trades 52.81% below its 50-day average.

    Beta (1Y)0.51
    52-Week Change-95.34%
    1-Month Change-36.02%
    3-Month Change-84.75%
    6-Month Change-84.32%
    Total Return (1Y)-95.34%
    Total Return (3Y CAGR)-45.08%
    Return vs SPY (1Y)-106.81%
    Max Drawdown (1Y)-95.72%
    Max Drawdown (3Y)-98.93%
    Sharpe Ratio (1Y)-2.50
    Correlation with SPY (1Y)0.06
    50-Day Average$3.20
    200-Day Average$9.88
    52-Week Range$1.31 to $33.60
    RSI (14 Days)31.8
    Average Volume (20 Days)28.30K

    Price chart

    Financial Position

    Current assets cover 0.69x current liabilities, and total debt is 3.62x shareholder equity.

    Current Ratio0.69x
    Quick Ratio0.61x
    Debt / Equity3.62x
    Interest Coverage-178.82x

    Returns and Efficiency

    Return on invested capital is -609.24% over the last 12 months, against a 5-year average of 123.85%.

    Return on Equity (ROE)-3559.87%
    Return on Assets (ROA)-285.18%
    Return on Invested Capital (ROIC)-609.24%
    ROIC (5Y Average)123.85%
    Asset Turnover0.07x
    Inventory Turnover0.22x
    Receivables Turnover3.24x
    Cash Conversion Cycle-1533 days

    Scores

    NXL has an Altman Z-Score of -51.95, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score-51.95
    Altman Z ZoneDistress
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $277.31K over the last 12 months is up 76.71% from the 12 months before.

    Revenue$277.31K
    Revenue Growth (YoY)+76.71%
    Gross Profit$228.58K
    Operating Income-$9.39M
    Pretax Income-$9.37M
    Net Income-$9.37M
    EBITDA-$9.25M
    Reported EPS (TTM)-$3.78

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 8.00% of the $3.29M in total assets.

    Cash and Equivalents$793.14K
    Total Debt$952.81K
    Net Debt$159.67K
    Net Debt Per Share$0.21
    Working Capital-$869.15K
    Shareholder Equity$263.34K
    Book Value Per Share$0.34
    Tangible Book Value-$819.63K
    Total Assets$3.29M
    Total Liabilities$3.02M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$6.25M
    FCF Per Share-$5.51
    Depreciation and Amortization$129.75K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -3386.02%.

    Gross Margin82.43%
    Operating Margin-3386.02%
    Pretax Margin-3380.59%
    Net Margin-3380.59%
    EBITDA Margin-3335.32%
    Gross Margin (5Y Average)78.48%

    Growth

    Revenue fell 38.88% a year over 3 years.

    Revenue Growth (3Y CAGR)-38.88%
    Revenue Growth (5Y CAGR)+4.43%
    Book Value Per Share Growth (2Y CAGR)-31.68%
    Tangible Book Per Share Growth (2Y CAGR)-33.72%

    Revenue and profit by year

    Dividends and Yields

    NXL does not pay a dividend.

    Buyback Yield-130.59%
    Shareholder Yield-130.59%

    Stock Splits

    The last split was a 1-for-30 reverse split on Aug 31, 2026.

    Last Split DateAug 31, 2026
    Split TypeReverse split
    Split Ratio1:30

    Peer Position

    Against 7 similar companies, NXL has the highest P/S.

    P/S Ratio4.2x vs 0.6x median
    ROIC-609.24% vs -147.05% median
    Revenue Growth (Trailing 4 Quarters, YoY)+76.71% vs +27.56% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.85% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.85%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NXL

    What is NXL's market cap?

    Nexalin Technology has a market cap of $1.93M. Its enterprise value, which adds debt and subtracts cash, is $2.09M.

    How many shares of NXL are outstanding?

    Nexalin Technology has 776.66K shares outstanding. The count is up 3832.21% from a year earlier.

    Does NXL pay a dividend?

    No. Nexalin Technology does not pay a dividend.

    How much debt does NXL have?

    Nexalin Technology has $952.81K of total debt and $793.14K of cash and equivalents, a net debt position of $159.67K.